Lesli Bell - Academia.edu (original) (raw)
Uploads
Papers by Lesli Bell
Rehabilitation Oncology, 2017
Rehabilitation Oncology, 2014
Rehabilitation Oncology, 2014
Rehabilitation Oncology, 2018
† The FDA currently recognizes only LLLT LTU-904 nm for lymphedema treatment (product code NZY). ... more † The FDA currently recognizes only LLLT LTU-904 nm for lymphedema treatment (product code NZY). While there are nearly 44 other LLLT laser devices that have received FDA clearance as "nonheating" for adjunctive use in pain therapy (product code NHN), it is critical to recognize that these devices have not been tested for, nor approved for, the treatment of lymphedema (https://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfPMN/pmn.cfm).
Rehabilitation Oncology, 2018
Archives of physical medicine and rehabilitation, Jan 9, 2018
To examine the validity of the self-report Work-Disability Functional Assessment Battery (WD-FAB)... more To examine the validity of the self-report Work-Disability Functional Assessment Battery (WD-FAB) physical function scales relative to clinician ratings of function and a performance-based functional capacity evaluation called the Physical Work Performance Evaluation (PWPE). Cross-sectional. Outpatient rehabilitation. Adults (N=50) participating in physical therapy for musculoskeletal conditions. Not applicable. Patients completed the PWPE and the WD-FAB physical function scales including Changing and Maintaining Body Position, Whole Body Mobility, Upper Body Function, and Upper Extremity Fine Motor. The physical therapist also answered the WD-FAB questions on the patient's physical functioning. The WD-FAB computer-adaptive test version administered up to 10 items for each scale. The PWPE produces ratings from 0 to 5 indicating overall Level of Work ability: 0 (unable to work); 1 (sedentary); 2 (light); 3 (medium); 4 (heavy); 5 (very heavy). The PWPE also produces Level of Work ...
Rehabilitation Oncology, 2019
E14 Bell et al Rehabilitation Oncology Fig. 4. Needle placement for treatment 3.
Rehabilitation Oncology, 2017
Rehabilitation Oncology, 2014
Rehabilitation Oncology, 2014
Rehabilitation Oncology, 2018
† The FDA currently recognizes only LLLT LTU-904 nm for lymphedema treatment (product code NZY). ... more † The FDA currently recognizes only LLLT LTU-904 nm for lymphedema treatment (product code NZY). While there are nearly 44 other LLLT laser devices that have received FDA clearance as "nonheating" for adjunctive use in pain therapy (product code NHN), it is critical to recognize that these devices have not been tested for, nor approved for, the treatment of lymphedema (https://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfPMN/pmn.cfm).
Rehabilitation Oncology, 2018
Archives of physical medicine and rehabilitation, Jan 9, 2018
To examine the validity of the self-report Work-Disability Functional Assessment Battery (WD-FAB)... more To examine the validity of the self-report Work-Disability Functional Assessment Battery (WD-FAB) physical function scales relative to clinician ratings of function and a performance-based functional capacity evaluation called the Physical Work Performance Evaluation (PWPE). Cross-sectional. Outpatient rehabilitation. Adults (N=50) participating in physical therapy for musculoskeletal conditions. Not applicable. Patients completed the PWPE and the WD-FAB physical function scales including Changing and Maintaining Body Position, Whole Body Mobility, Upper Body Function, and Upper Extremity Fine Motor. The physical therapist also answered the WD-FAB questions on the patient's physical functioning. The WD-FAB computer-adaptive test version administered up to 10 items for each scale. The PWPE produces ratings from 0 to 5 indicating overall Level of Work ability: 0 (unable to work); 1 (sedentary); 2 (light); 3 (medium); 4 (heavy); 5 (very heavy). The PWPE also produces Level of Work ...
Rehabilitation Oncology, 2019
E14 Bell et al Rehabilitation Oncology Fig. 4. Needle placement for treatment 3.